Search results for "Atrial fibrillation"
Non-aspirin NSAIDs associated with risk for atrial fibrillation or flutter, study finds
Nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase (COX)-2 inhibitors may be associated with increased risk for atrial fibrillation or flutter, according to a new study.
https://immattersacp.org/weekly/archives/2011/07/12/2.htm
12 Jul 2011
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023
MKSAP Quiz: Follow-up on ED visit
A 31-year-old man is evaluated for follow-up 2 days after an emergency department visit for palpitations. He reports intermittent palpitations and occasional episodes of shortness of breath. What is the most appropriate next step in management?
https://immattersacp.org/archives/2017/06/mksap.htm
1 Jun 2017
Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy
A retrospective analysis of Medicare patients who started an anticoagulant and then amiodarone found that they had a 44% increased risk for bleeding-related hospitalization compared to those on other antiarrhythmics and that this risk was higher with rivaroxaban than apixaban.
https://immattersacp.org/weekly/archives/2023/05/23/1.htm
23 May 2023
Top 10 afib pearls manage cardiology's ‘bread and butter’
Atrial fibrillation has been called “the bread and butter” of cardiology, and a condition that impacts all aspects of internal medicine practice.
https://immattersacp.org/archives/2015/06/afib.htm
1 Jun 2015
Incidentally detected bradyarrhythmias not associated with worse outcomes in older patients
Bradyarrhythmias were found in 20.8% of patients ages 70 years and older who were given an implantable loop recorder compared to 3.8% in a control group, but detection and treatment were not associated with risk of syncope or sudden death, a Danish study found.
https://immattersacp.org/weekly/archives/2023/02/21/1.htm
21 Feb 2023
Task Force finds insufficient evidence on screening for afib
The U.S. Preventive Services Task Force reviewed trials published since 2017 but did not deem them strong enough to show evidence of benefit or harm.
https://immattersacp.org/weekly/archives/2022/02/01/3.htm
1 Feb 2022
Subclinical hypothyroidism prompts personalized decisions
For diagnosing and managing subclinical hypothyroidism, clinical context such as age and symptoms matter, even in the face of an incomplete understanding of the condition.
https://immattersacp.org/archives/2021/02/subclinical-hypothyroidism-prompts-personalized-decisions.htm
1 Feb 2021
Rivaroxaban noninferior to warfarin for stroke, embolism in atrial fibrillation
Rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism in patients with atrial fibrillation, a study found.
https://immattersacp.org/weekly/archives/2011/08/16/4.htm
16 Aug 2011
A can't-miss cause of resistant hypertension
More than 20% of patients with resistant hypertension have primary aldosteronism, an underrecognized cause of hypertension and cardiovascular disease.
https://immattersacp.org/archives/2021/05/a-cant-miss-cause-of-resistant-hypertension.htm
1 May 2021